BioAsia 2026, the 23rd edition of Asia’s premier life sciences and health-tech forum, was released by Telangana minister for IT, electronics & communications, and industries & commerce, D Sridhar Babu.
The poster release marked the ceremonial commencement of preparations for the upcoming summit scheduled to be held from February 16-18, 2026 in Hyderabad.
Over the past two decades, BioAsia has emerged as Asia’s foremost platform for life sciences, biopharma, health-tech, and medical innovation, consistently bringing together global leaders, investors, innovators, researchers, and policymakers. Each edition has showcased cutting-edge science while reinforcing Hyderabad and Telangana’s position as a global hub for biopharma, vaccines, medtech, and digital health innovation, supported by world-class infrastructure and a deep pool of scientific talent.
The 23rd edition of BioAsia theme ‘TechBio Unleashed: AI, Automation & the Biology Revolution,’ reflects the pivotal convergence of biology, data, and deep technology that is reshaping drug discovery, diagnostics, manufacturing of therapies, and healthcare delivery globally. TechBio is transforming how diseases are understood, how therapies are designed, and how care is delivered—making healthcare more predictive, personalized, and accessible while strengthening a resilient and inclusive global health system.
Minister Babu said, “As Telangana embarks its journey towards becoming a $3 trillion economy by 2047, Lifesciences sector will play a critical role in shaping the growth of the state. Marquee event like BioAsia showcases Telangana’s leadership in life sciences and healthcare innovation and acts as a pivotal platform to foster new partnerships and explore opportunities for growth in this segment.”
Sanjay Kumar, special chief secretary, industries & commerce and ITE & C Departments, Government of Telangana said “BioAsia 2026 will provide a powerful platform for collaboration among startups, researchers, industry leaders, and policymakers.”
Shakthi Nagappan, CEO, Telangana Life Sciences Foundation, said, “As biology converges with AI, automation and data, we see unprecedented opportunities for innovation, investment and impact. This edition of BioAsia will not just be a forum for discussions, but a platform to translate ideas into action by bringing together startups, global companies, researchers and policymakers to collaboratively shape the future of healthcare from Hyderabad to the world.”
The summit is expected to deliver strategic value for startups, researchers, investors, policymakers, and global organizations. BioAsia 2026 will connect innovators with investors, act as a bridge between laboratory breakthroughs and market adoption, and provide a forum for policymakers to co-create regulatory frameworks that encourage innovation while safeguarding patient safety and public interest. |